Travere Therapeutics, Inc. · NASDAQ:TVTX
Meckler Jeffrey A sold 8,000 Travere Therapeutics, Inc. shares (Form 4)
Traded May 4, 2026 · Filed May 6, 2026
On May 4, 2026, Meckler Jeffrey A (Director) sold 8,000 Travere Therapeutics, Inc. shares at US$45.00 for US$360K under a trading plan, leaving 87,500 shares. Filed May 6, 2026 (Form 4).
- Sold
- 8,000 shares
- Price
- US$45.00
- Value
- US$360K
- Holding after
- 87,500 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 8,000 | US$16.33 | 95,500 | Direct |
| May 4, 2026 | Common Stock | Sale | 8,000 | US$45.00 | 87,500 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Meckler Jeffrey A
- Travere Therapeutics, Inc. shareholders
- Form 4 · Meckler Jeffrey A · Sep 11, 2026
- Form 4 · Meckler Jeffrey A · May 21, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026